コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion," "cross-reactivity," and "antimicrobial stewardship".
2 bing during hospitalization (fluoroquinolone stewardship).
3 otics is an important tool for antimicrobial stewardship.
4 nd minimal desirable standards of antibiotic stewardship.
5 days following introduction of antimicrobial stewardship.
6 due to these organisms and for antimicrobial stewardship.
7 ect patient treatment and improve antibiotic stewardship.
8 and Prevention's Core Elements of Antibiotic Stewardship.
9 ision-care algorithms, and active antibiotic stewardship.
10 are to identify opportunities for antibiotic stewardship.
11 are opportunities for improved antimicrobial stewardship.
12 ulture bottles to help improve antimicrobial stewardship.
13 rial infections and to facilitate antibiotic stewardship.
14 l antibiotic consumption and a potential for stewardship.
15 promoting responsible antimicrobial use and stewardship.
16 nce has broad implications for antimicrobial stewardship.
17 cuss coordinated approaches to antimicrobial stewardship.
18 nformed therapy decisions and aid antifungal stewardship.
19 ce-based treatment and promote antimicrobial stewardship.
20 as opioid abuse prevention and antimicrobial stewardship.
21 n hospitals with and without fluoroquinolone stewardship.
22 proved clinical management and antimicrobial stewardship.
23 ip Group (ARLG) in the area of antibacterial stewardship.
24 hogens and an integral part of antimicrobial stewardship.
25 ection prevention measures and antimicrobial stewardship.
26 en advocated as a useful tool for antibiotic stewardship.
27 ces of inaction, and the need for antibiotic stewardship.
28 r individual patient outcomes and antibiotic stewardship.
29 global science-business initiative for ocean stewardship.
30 rough infection prevention and antimicrobial stewardship.
31 are opportunities for improved antimicrobial stewardship.
32 not in alignment with prudent antimicrobial stewardship.
33 dhere to the FAIR guiding principles of data stewardship.
34 95% CI 0.23-3.48, p=0.025) during antibiotic stewardship.
35 <0.0001) in the community, during antibiotic stewardship.
36 cteraemia may be of benefit in antimicrobial stewardship.
37 e improve patient outcomes and antimicrobial stewardship.
38 atients; and opinions regarding gift use and stewardship.
39 are to identify opportunities for antibiotic stewardship.
40 is an effective and sustainable approach to stewardship.
41 d and is a challenging subject in antifungal stewardship.
42 velop plans for long-term responsibility and stewardship.
43 stants, are important targets for antibiotic stewardship.
44 n is needed to guide pediatric antimicrobial stewardship.
45 We test a novel approach to antibiotic stewardship.
46 ctive in many areas supporting antimicrobial stewardship.
47 These data may inform perioperative stewardship.
48 optimize resource utilization and radiation stewardship.
49 f asymptomatic bacteriuria aid in antibiotic stewardship.
50 We propose potential solutions that tailor stewardship activities to the needs of the facility and
51 days following introduction of antimicrobial stewardship (adjusted intervention effect -12.12 defined
52 iene, environmental cleaning, and antibiotic stewardship); advanced infection control practices (ie,
56 Building on its experience of antimicrobial stewardship (AMS) advocacy, the Infectious Diseases Soci
57 owever, suitable approaches to antimicrobial stewardship (AMS) in low-income settings are not well st
58 y recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decr
60 tic allergy testing (AAT) into antimicrobial stewardship (AMS) programs (AAT-AMS) is not widespread.
62 minireview outlines the roles of diagnostic stewardship and antimicrobial stewardship in the impleme
66 s have important implications for antibiotic stewardship and public health policies and, in particula
67 environmental policy to foster environmental stewardship and public participation, crucial prerequisi
68 be developed in order to improve antibiotic stewardship and reduce the emergence of antibiotic resis
69 s have important implications for antibiotic stewardship and should be considered as new policies for
75 ntibiotic and possibly proton pump inhibitor stewardship, and prescribing prophylactic vancomycin and
76 e crisis, the implications for antimicrobial stewardship, and some novel opportunities to limit resis
77 d hospital leadership support for antibiotic stewardship appears to drive the establishment of ASPs.
81 mes in men with NGU and better antimicrobial stewardship are likely to arise from the introduction of
82 er, diagnostic stewardship and antimicrobial stewardship are necessary to ensure that these technolog
84 n of resistance, combined with antimicrobial stewardship, are key interventions to combat the spread
91 sectors have been inconsistent at antibiotic stewardship, but it is unclear which sector has most inf
92 allergy labels directly impact antimicrobial stewardship by leading to use of less effective and broa
93 ado created a unique method of antimicrobial stewardship, called handshake stewardship, that effectiv
98 eraged to foster transnational environmental stewardship, critical to advancing global sustainability
100 r improving both patient care and antibiotic stewardship, despite the tendency for positive results w
101 acquired infection prevention, antimicrobial stewardship, disease surveillance, and outbreak response
102 educes apparent AU variation and may enhance stewardship efforts by providing adjusted comparisons to
103 eating this common condition, and antibiotic stewardship efforts in transplantation may help preserve
106 improved patient care, utility in targeting stewardship efforts, and feasibility in hospitals with e
113 aetiologies, implementation of antimicrobial stewardship guidelines across Europe is necessary to lim
114 ischarge, and hospitals with fluoroquinolone stewardship had twice as many new fluoroquinolone starts
115 ch of the national attention with regards to stewardship has focused on primary care providers, there
119 t the urgent need for enhanced antimicrobial stewardship in a high-growth industry with broad links t
123 tcomes indicate that effective antimicrobial stewardship in long-term care is supported by incorporat
124 ld effectively and safely improve antibiotic stewardship in patients with clinically suspected ventil
125 mprove clinical management and antimicrobial stewardship in patients with less frequent Gram-negative
127 d, second, whether it improves antimicrobial stewardship in the era of increasing numbers of urinary
128 of diagnostic stewardship and antimicrobial stewardship in the implementation of rapid molecular inf
132 diseases (ID) consultation and antimicrobial stewardship intervention have been shown to improve the
133 ies evaluating rapid diagnostic testing plus stewardship intervention have consistently demonstrated
134 iations between a primary care antimicrobial stewardship intervention in 2009 and primary care prescr
136 examined the effect of a national antibiotic stewardship intervention limiting the use of 4C antibiot
137 A mixed persuasive-restrictive 4C antibiotic stewardship intervention was initiated in all population
146 ntal implementation study of 2 antimicrobial stewardship interventions in a hematological malignancy
147 ment of antimicrobial policy and appropriate stewardship interventions specific for the COVID-19 pand
148 port the importance of developing antibiotic stewardship interventions specifically targeting UC sett
150 WaRe) classification could facilitate simple stewardship interventions that are widely applicable glo
151 control of overall MDRO burden will require stewardship interventions that take into account both pr
152 ht opportunities for community antimicrobial stewardship interventions to improve antibiotic use by a
153 treatment should be targeted with antibiotic stewardship interventions to improve UTI treatment.
156 ibiotic prescribing, implementing antibiotic stewardship interventions, obtaining financial resources
161 nnecessary use of antifungals via antifungal stewardship is critical to limit multidrug resistance em
172 e turnaround times and enhance antimicrobial stewardship, multiple point-of-care assays have been dev
173 ic infectious diseases (including antibiotic stewardship), nursing, pharmacy, a patient advocate and
174 ic infectious diseases (including antibiotic stewardship), nursing, pharmacy, a patient advocate, and
181 eded to inform next steps in the responsible stewardship of this process, from the perspective of tra
184 esholds may provide quantitative targets for stewardship-optimizing the control of resistance while a
185 sion persists about the specific set of land stewardship options available and their mitigation poten
187 maceutical companies invest in antimicrobial stewardship, outlines why they are well suited to help a
189 anism identification and dedicating pharmacy stewardship personnel time on the total hospital costs.
190 menting MALDI-TOF and of dedicating pharmacy stewardship personnel time to interventions, the total h
192 resistance, designing antibiotic resistance stewardship policy, and interpreting stewardship interve
194 Antibiotic Stewardship Programs, we analyzed stewardship practices as reported in the 2015 National H
199 ting (BLAST) is recommended by antimicrobial stewardship program (ASP) guidelines, yet few studies ha
200 l diagnostics with and without antimicrobial stewardship program (ASP) intervention, and rapid diagno
203 r rapid platforms coupled with antimicrobial stewardship program (ASP) real-time notification (RTN) h
204 valuating standard care (STD), antimicrobial stewardship program (ASP), environmental cleaning (ENV),
210 study evaluating the impact of a diagnostic stewardship program that aimed to optimize BCx use in a
211 f a unique in-person pediatric antimicrobial stewardship program was associated with a significant in
216 sessed the effectiveness of an antimicrobial stewardship programme aiming to reduce inappropriate ant
219 eloping and evaluating paediatric antibiotic stewardship programmes on the basis of the AWaRe index.
220 guidelines, antibiotic formulary, antibiotic stewardship programmes, public health interventions, inf
223 of medication-related errors, antiretroviral stewardship programs (ARVSPs) are needed to enhance pati
224 trated that the combination of antimicrobial stewardship programs (ASP) and rapid organism identifica
225 s authorities have recommended Antimicrobial Stewardship Programs (ASP) to curb the selection of AMR
226 ower with mRDT in studies with antimicrobial stewardship programs (ASPs) (OR, 0.64; 95% CI, .51-.79),
232 de-labeling into a new arm of antimicrobial stewardship programs (ASPs) has become an increasing glo
235 ld experience from established antimicrobial stewardship programs (ASPs) on how institutions can comp
238 s authorities have recommended antimicrobial stewardship programs (ASPs) to curb the selection of AMR
239 in 2015 as a tool for hospital antimicrobial stewardship programs (ASPs) to track and compare AU with
242 , particularly given the new requirement for stewardship programs by the Centers for Medicare and Med
246 is modeled upon the success of antimicrobial stewardship programs now mandated by the Joint Commissio
247 ions for hospital formularies and antibiotic stewardship programs regarding positioning of these agen
249 To limit aggregate fluoroquinolone exposure, stewardship programs should target both inpatient and di
250 This study demonstrates that antimicrobial stewardship programs support, and do not compete with, i
251 ntion's Core Elements of Hospital Antibiotic Stewardship Programs, we analyzed stewardship practices
258 re, there is a significant need for improved stewardship related to diagnostic testing for and treatm
260 ts to control C difficile through antibiotic stewardship should account for ribotype distributions an
262 o mitigate their ill effects; and antibiotic stewardship should be a part of every surgeons' practice
263 Consequently, efforts to improve antibiotic stewardship should be coupled with improving hygiene con
265 sion (TJC) recently issued new antimicrobial stewardship standards, consisting of 8 elements of perfo
267 inform rational antimicrobial treatment and stewardship strategies, and models for market reform and
273 ng, pragmatic interventions on antimicrobial stewardship targeting providers and caregivers substanti
274 g models (diagnosis-related group carve-out, stewardship taxes, transferable exclusivity voucher, and
275 ll hospitals when constructing an antibiotic stewardship team, obtaining appropriate metrics of antib
276 ngle time-outs without input from antibiotic stewardship teams are insufficient to optimize prescribi
277 n addition to exploring the effectiveness of stewardship techniques in community hospitals, the ARLG
278 is a high-priority target for antimicrobial stewardship that has not been described for cancer patie
279 tutional initiatives) will enable the robust stewardship that is needed to address the current crisis
280 antimicrobial stewardship, called handshake stewardship, that effectively decreased hospital anti-in
281 developed different approaches to antibiotic stewardship-the USA, South Africa, Colombia, Australia,
282 tive new antibiotics to improving antibiotic stewardship through financial mechanisms and regulation.
283 o existing pressures and shift towards ocean stewardship through incorporation of niche innovations w
284 vide a vital component for use in laboratory stewardship to curtail unnecessary respiratory viral tes
285 NPVs, MRSA nares screening may be a powerful stewardship tool for de-escalation and avoidance of empi
286 Vs with MRSA nares screening maybe used as a stewardship tool for de-escalation as well as avoidance
287 NPVs, MRSA nares screening may be a powerful stewardship tool for deescalation and avoidance of empir
289 sts without residency or prior antimicrobial stewardship training were trained to conduct prospective
292 e in mortality associated with antimicrobial stewardship using audit and feedback in the ICU setting.
297 derstand shifts in selective pressure due to stewardship, we use publicly available data to estimate
300 tures of change towards 'corporate biosphere stewardship', with significant potential for upscaling.